Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
시장 타임라인 및 시그널 피드 잠금 해제
최근 90일간 시그널 306건.
이 회사가 각 시장에 진입한 순서 — 오래된 순부터 최신 순까지
13 active postings
70 active postings
가입하고 전체 시그널 피드를 확인하세요
Galderma의 글로벌 확장이 경쟁사와 비교해 어떤지
Galderma본 회사막대는 비교 대상 회사 간 상대적 규모를 나타냅니다.
열5| 회사 | 시장 | 신규 시장 | 모멘텀 | 활동 | 확장 점수 |
|---|---|---|---|---|---|
 Galderma본 회사 | 34 | 0 | -57% | 250 | 35 |
Opérateur de Production Conditionnement FDS Jour
공고 보기Baie-d’Urfé, Quebec, Canada · 어제
Employee Relations / Labor Relations (ER / LR) Specialist (Part-time position / 50%)
공고 보기Warsaw, Mazowieckie, Poland · 어제
Sales Representative (Injectable Aesthetics) - Western Cape Town
공고 보기Johannesburg, Gauteng, South Africa · 그저께
We’re excited to share insights from our new global anti-wrinkle treatment survey, revealing a clear shift in preferences toward high-performance solutions that deliver lasting results and drive innovation in aesthetics.Anti-wrinkle treatments are one of the most common injectable procedures in aesthetics. Results show that healthcare professionals prioritize performance above all. For patients, the value lies in both emotional impact and visible performance, with long-lasting and early results ...
종료됨We’re excited to share insights from our new global anti-wrinkle treatment survey, revealing a clear shift in preferences toward high-performance solutions that deliver lasting results and drive innovation in aesthetics.Anti-wrinkle treatments are one of the most common injectable procedures in aesthetics. Results show that healthcare professionals prioritize performance above all. For patients, the value lies in both emotional impact and visible performance, with long-lasting and early results ...
종료됨At Galderma, the President’s Club Awards are an opportunity to recognize our top-performing Sales colleagues from around the world. This year we held two exceptional events - first, in May, our leading U.S. Sales colleagues gathered in Cap Cana, Dominican Republic, for a well-earned celebration of their remarkable achievements.Then, just this past week, our top Sales colleagues from LATAM, EMEAC and JPAC joined together in Singapore, all in one place for the very first time. These celebrations r ...
종료됨갈더마코리아, 민감 피부용 각질 케어 세타필 SA 라인 출시. 삼중 필링 성분과 보습 성분 함유한 클렌저와 로션 2종 제품 선보여.
갈더마가 아토피 피부염과 결절성 가려움 발진 치료를 위한 IL-31 억제제 네몰리주맙을 한국에서 승인받아 생물학적 제제 시장에 진출했다.
갈더마코리아가 아토피 피부염과 결절성 가려움 발진의 가려움을 표적하는 IL-31 억제제 넴루비오를 소개했다. 임상시험에서 48시간 내 가려움 완화와 유의한 EASI 개선을 보였다. 급여 신청 완료, 2027년 초 출시 목표.
인증된 이메일과 직통 전화 잠금 해제
무료 · 신용카드 불필요
Galderma의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.
© 2026 Pubrio. 모든 권리 보유.
